Abstract
We studied the biochemical markers of bone metabolism and bone mineral density (BMD) in 43 male haemodialysis patients. We measured serum levels of carboxyterminal parathyroid hormone (PTH-c), carboxyterminal propeptide of human type I procollagen, calcitonin, intact osteocalcin, cross-linked carboxyterminal telopeptide of human type I collagen, and alkaline phosphatase. We divided all patients into 2 groups (group A and B), those with serum PTH-c levels of 7.5 ng/ml or higher, and those with levels lower than 7.5 ng/ml, respectively. In group A, the levels of markers for bone formation and for bone resorption were notably elevated, while BMD was not significantly decreased. The level of serum markers for bone metabolism appears to be more sensitive than BMD for the clinical assessment of secondary hyperparathyroidism.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
